LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

NCT06198413 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-Related Macular Degeneration

Interventions

GENETIC: LX102 subretinal injection

Sponsor

Innostellar Biotherapeutics Co.,Ltd